Huang et al. [122] found that TAM-derived CCL5 promotes prostate cancer cell self-renewal and that knocking CCL5 out of TAMs suppresses xenograft growth, bone metastasis, and self-renewal properties of these cells, confirming their role in β-catenin/STAT3 signaling. Here, CCL5 is linked to prostate cancer.